AKEBIA THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

20 فبراير 2026 10:10:40 بحسب NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

17 فبراير 2026 10:52:51 بحسب NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

13 فبراير 2026 13:06:39 بحسب NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

20 يناير 2026 09:46:18 بحسب NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

13 يناير 2026 10:03:31 بحسب NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

12 يناير 2026 09:46:26 بحسب NetDania Notify

Akebia Therapeutics Announces Corporate Updates and 2026 Pipeline Outlook

12 يناير 2026 08:00:00 بحسب Nasdaq GlobeNewswire

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Praliciguat for the Treatment of Focal Segmental Glomerulosclerosis (FSGS)

06 يناير 2026 08:00:01 بحسب Nasdaq GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 يناير 2026 16:05:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

02 ديسمبر 2025 10:42:52 بحسب NetDania Notify

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 ديسمبر 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Akebia Announces Establishment of Rare Kidney Disease Pipeline

01 ديسمبر 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Akebia Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

24 نوفمبر 2025 08:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

21 نوفمبر 2025 09:45:05 بحسب NetDania Notify

Akebia Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

10 نوفمبر 2025 07:00:01 بحسب Nasdaq GlobeNewswire

Vafseo® (vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs. ESAs

06 نوفمبر 2025 18:30:00 بحسب Nasdaq GlobeNewswire

Akebia Therapeutics to Present at Upcoming Investor Conferences

04 نوفمبر 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 نوفمبر 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Akebia Therapeutics to Report Third Quarter 2025 Financial Results and Discuss Recent Business Highlights

30 أكتوبر 2025 08:00:01 بحسب Nasdaq GlobeNewswire

Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients

28 أكتوبر 2025 16:30:00 بحسب Nasdaq GlobeNewswire